試す 金 - 無料
Keeps Your Risk Factors Under Complete Control
Bio Spectrum
|Decemeber 2019
Sartorius introduced the very first Sartocheck ® Filter Integrity Tester in 1980 and over a period spanning more than 3 decades, Sartocheck ® Filter Integrity Tester evolved into an extremely sophisticated automated integrity test solution which is preferred by customers across the globe.
-
Sartocheck ® 5 Plus Filter Integrity Tester, the latest upgrade to the Sartocheck ® product line, is the outcome of extensive research and customer-centric approach to optimize the detection of operator errors, improper test setups, and out-of-tolerance environmental conditions. Its patented software and sensor technologies make the new Sartocheck ® 5 Plus Filter Integrity Tester the most advanced filter integrity tester yet that surpasses the requirements of Quality Risk Management (QRM). All these elements ensured that Sartocheck ® 5 Plus Filter Integrity Tester wins the iF Design Award in 2018. This is how Sartocheck ® 5 Plus Filter Integrity Tester meets key industry requirements for filter integrity testing even in the most demanding environments.
Automatic detection of incorrect test setups and test conditions
All diffusion and WIT programs can be defined with a minimum expected value. If the measured value falls below that setting it is evident that something is wrong, for example, the filter being tested is blocked, the wrong filter type is being tested or the downstream valve is closed. The bubble point programs can be defined with a minimum flow expected to be achieved at the end pressure of the test.
If the actual bubble point exceeds a certain level it is considered atypical. The BPmax (if set to lower than Pend) allows detection of these atypical situations. Pend is set in order not to exceed the pressure resistance of the filter setup and will terminate the test, even if the bubble point has not been reached.
When a filter is being tested, it always generates a certain pressure decay. If a pressure increase is detected instead of a pressure decay, it may indicate a temperature change or that the downstream side of the filter is being pressurized.
Faster Testing
このストーリーは、Bio Spectrum の Decemeber 2019 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Bio Spectrum からのその他のストーリー
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Translate
Change font size

